AIBORN Co., Ltd. received a new investment from Medical Data Vision Inc. to enhance its medical record AI tool Katanashi and strengthen their partnership for wider adoption in Japan's healthcare sector.
AIBORN has announced a new investment from Medical Data Vision Inc. to deepen their collaboration. This funding will enhance the adoption of AIBORN's software across medical institutions in Japan. The capital will be used for product development and post-implementation support
Company Information
Company
AIBORN Ltd
Location
Japan
About
AIBORN is a company based in Chuo-ku, Tokyo, that develops the medical record AI tool Katanashi. The company focuses on reducing the administrative burden of healthcare professionals through their AI-powered software, which transcribes patient consultations and meetings into streamlined clinical documentation formats. AIBORN aims to enhance the efficiency of medical institutions by providing advanced technological solutions. Led by President and CEO Shohei Toyama, AIBORN is committed to improving healthcare workflows.
Fundz sees it the moment AIBORN Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
JapanBiotechnologySoftwareHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth Diagnostics